TreeWAS – Variant ID: rs9266825

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
K90.0 Coeliac disease	0.000	0.000	1.000
L40.9 Psoriasis, unspecified	1.000	0.000	0.000
L40.5 Arthropathic psoriasis	1.000	0.000	0.000
M45.X9 Ankylosing spondylitis (Site unspecified)	1.000	0.000	0.000
L40 Psoriasis	1.000	0.000	0.000
M07.3 Other psoriatic arthropathies	1.000	0.000	0.000
M07.30 Other psoriatic arthropathies (Multiple sites)	1.000	0.000	0.000
M45 Ankylosing spondylitis	1.000	0.000	0.000
M07.39 Other psoriatic arthropathies (Site unspecified)	0.999	0.001	0.000
M45.X0 Ankylosing spondylitis (Multiple sites in spine)	0.999	0.001	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.997	0.003	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.996	0.004	0.000
T43.2 Other and unspecified antidepressants	0.994	0.006	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.992	0.008	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.985	0.015	0.000
S01 Open wound of head	0.000	0.022	0.978
L40.0 Psoriasis vulgaris	0.977	0.023	0.000
S00-S09 Injuries to the head	0.000	0.024	0.976
S02 Fracture of skull and facial bones	0.000	0.031	0.969
J45.9 Asthma, unspecified	0.000	0.032	0.968
S01.3 Open wound of ear	0.000	0.041	0.959
S00 Superficial injury of head	0.000	0.042	0.958
S01.8 Open wound of other parts of head	0.000	0.043	0.957
T39.1 4-Aminophenol derivatives	0.955	0.045	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.955	0.045	0.000
M45.X2 Ankylosing spondylitis (Cervical region)	0.947	0.053	0.000
T42.4 Benzodiazepines	0.937	0.063	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.937	0.063	0.000
M07.37 Other psoriatic arthropathies (Ankle and foot)	0.936	0.064	0.000
J45 Asthma	0.000	0.068	0.932
S02.4 Fracture of malar and maxillary bones	0.000	0.076	0.924
S00.1 Contusion of eyelid and periocular area	0.000	0.080	0.920
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.920	0.080	0.000
S02.8 Fractures of other skull and facial bones	0.000	0.089	0.911
S01.1 Open wound of eyelid and periocular area	0.000	0.104	0.896
S06 Intracranial injury	0.000	0.105	0.895
J45.0 Predominantly allergic asthma	0.000	0.105	0.895
S02.40 Fracture of malar and maxillary bones (closed)	0.000	0.107	0.893
M07.34 Other psoriatic arthropathies (Hand)	0.886	0.114	0.000
M07.36 Other psoriatic arthropathies (Lower leg)	0.880	0.120	0.000
S00.3 Superficial injury of nose	0.000	0.122	0.878
S02.80 Fractures of other skull and facial bones (closed)	0.000	0.131	0.869
S02.6 Fracture of mandible	0.000	0.131	0.869
S01.7 Multiple open wounds of head	0.000	0.134	0.866
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.866	0.134	0.000
S00.2 Other superficial injuries of eyelid and periocular area	0.000	0.151	0.849
M07.35 Other psoriatic arthropathies (Pelvic region and thigh)	0.836	0.164	0.000
L40.1 Generalised pustular psoriasis	0.829	0.171	0.000
L40.4 Guttate psoriasis	0.827	0.173	0.000
M45.X6 Ankylosing spondylitis (Lumbar region)	0.826	0.174	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.826	0.174	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.823	0.177	0.000
S01.4 Open wound of cheek and temporomandibular area	0.000	0.178	0.821
K90 Intestinal malabsorption	0.000	0.181	0.819
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.814	0.186	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.810	0.190	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.799	0.201	0.000
S00.7 Multiple superficial injuries of head	0.000	0.202	0.798
L40.8 Other psoriasis	0.798	0.202	0.000
S02.60 Fracture of mandible (closed)	0.000	0.203	0.797
S06.2 Diffuse brain injury	0.000	0.203	0.797
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.793	0.207	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.790	0.210	0.000
M07.31 Other psoriatic arthropathies (Shoulder region)	0.790	0.210	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.788	0.212	0.000
T38.1 Thyroid hormones and substitutes	0.781	0.219	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.773	0.226	0.000
T39.0 Salicylates	0.772	0.228	0.000
S00.5 Superficial injury of lip and oral cavity	0.000	0.228	0.772
T42.1 Iminostilbenes	0.771	0.229	0.000
S02.9 Fracture of skull and facial bones, part unspecified	0.000	0.229	0.771
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.770	0.230	0.000
J33.0 Polyp of nasal cavity	0.000	0.230	0.770
T42.0 Hydantoin derivatives	0.764	0.235	0.000
S06.3 Focal brain injury	0.000	0.236	0.764
J33 Nasal polyp	0.000	0.237	0.763
S01.5 Open wound of lip and oral cavity	0.000	0.243	0.757
T50.8 Diagnostic agents	0.753	0.247	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.753	0.247	0.000
J40-J47 Chronic lower respiratory diseases	0.000	0.253	0.747
K90.9 Intestinal malabsorption, unspecified	0.000	0.253	0.747
S02.7 Multiple fractures involving skull and facial bones	0.000	0.257	0.743
Chapter X Diseases of the respiratory system	0.000	0.260	0.740
J80-J84 Other respiratory diseases principally affecting the interstitium	0.000	0.266	0.734
J84 Other interstitial pulmonary diseases	0.000	0.267	0.733
J30-J39 Other diseases of upper respiratory tract	0.000	0.267	0.733
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.728	0.272	0.000
S06.20 Diffuse brain injury (without open intracranial wound)	0.000	0.274	0.726
S06.6 Traumatic subarachnoid haemorrhage	0.000	0.279	0.721
J30 Vasomotor and allergic rhinitis	0.000	0.279	0.721
L40.3 Pustulosis palmaris et plantaris	0.717	0.283	0.000
L40.2 Acrodermatitis continua	0.717	0.283	0.000
M07.38 Other psoriatic arthropathies (Other)	0.717	0.283	0.000
M07.33 Other psoriatic arthropathies (Forearm)	0.717	0.283	0.000
M07.32 Other psoriatic arthropathies (Upper arm)	0.717	0.283	0.000
M45.X8 Ankylosing spondylitis (Sacral and sacrococcygeal region)	0.717	0.283	0.000
M45.X7 Ankylosing spondylitis (Lumbosacral region)	0.717	0.283	0.000
M45.X5 Ankylosing spondylitis (Thoracolumbar region)	0.717	0.283	0.000
M45.X4 Ankylosing spondylitis (Thoracic region)	0.717	0.283	0.000
M45.X3 Ankylosing spondylitis (Cervicothoracic region)	0.717	0.283	0.000
M45.X1 Ankylosing spondylitis (Occipito-atlanto-axial region)	0.717	0.283	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.715	0.285	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.715	0.285	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.714	0.285	0.000
T43.9 Psychotropic drug, unspecified	0.714	0.286	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.714	0.286	0.000
J84.1 Other interstitial pulmonary diseases with fibrosis	0.000	0.286	0.714
T43.6 Psychostimulants with abuse potential	0.713	0.287	0.000
J30.1 Allergic rhinitis due to pollen	0.000	0.288	0.712
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.711	0.288	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.711	0.288	0.000
T42.3 Barbiturates	0.711	0.288	0.000
T42.2 Succinimides and oxazolidinediones	0.711	0.288	0.000
S02.2 Fracture of nasal bones	0.000	0.291	0.709
T39.4 Antirheumatics, not elsewhere classified	0.706	0.294	0.000
T39.2 Pyrazolone derivatives	0.706	0.294	0.000
S00.0 Superficial injury of scalp	0.000	0.295	0.705
S08 Traumatic amputation of part of head	0.000	0.300	0.700
S07 Crushing injury of head	0.000	0.300	0.700
S04 Injury of cranial nerves	0.000	0.300	0.700
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.699	0.300	0.000
K90.8 Other intestinal malabsorption	0.000	0.301	0.699
J33.9 Nasal polyp, unspecified	0.000	0.303	0.697
S06.9 Intracranial injury, unspecified	0.000	0.306	0.694
T50.6 Antidotes and chelating agents, not elsewhere classified	0.692	0.308	0.000
S01.2 Open wound of nose	0.000	0.309	0.691
J84.9 Interstitial pulmonary disease, unspecified	0.000	0.310	0.690
S03 Dislocation, sprain and strain of joints and ligaments of head	0.000	0.310	0.690
T46 Poisoning by agents primarily affecting the cardiovascular system	0.689	0.311	0.000
N47 Redundant prepuce, phimosis and paraphimosis	0.000	0.312	0.688
J95-J99 Other diseases of the respiratory system	0.000	0.321	0.679
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.672	0.327	0.000
T50.7 Analeptics and opioid receptor antagonists	0.671	0.328	0.000
T50.5 Appetite depressants	0.671	0.328	0.000
T50.4 Drugs affecting uric acid metabolism	0.671	0.328	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.671	0.328	0.000
T50.1 Loop [high-ceiling] diuretics	0.671	0.328	0.000
T50.0 Mineralocorticoids and their antagonists	0.671	0.328	0.000
S06.30 Focal brain injury (without open intracranial wound)	0.000	0.329	0.671
S02.5 Fracture of tooth	0.000	0.330	0.670
J99 Respiratory disorders in diseases classified elsewhere	0.000	0.331	0.669
T36 Poisoning by systemic antibiotics	0.669	0.331	0.000
J45.8 Mixed asthma	0.000	0.332	0.668
J45.1 Nonallergic asthma	0.000	0.332	0.668
J99.8 Respiratory disorders in other diseases classified elsewhere	0.000	0.334	0.666
S02.41 Fracture of malar and maxillary bones (open)	0.000	0.337	0.663
T38.9 Other and unspecified hormone antagonists	0.659	0.340	0.000
T38.7 Androgens and anabolic congeners	0.659	0.340	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.659	0.340	0.000
T38.5 Other oestrogens and progestogens	0.659	0.340	0.000
T38.4 Oral contraceptives	0.659	0.340	0.000
T38.2 Antithyroid drugs	0.659	0.340	0.000
T38.0 Glucocorticoids and synthetic analogues	0.659	0.340	0.000
S02.81 Fractures of other skull and facial bones (open)	0.000	0.347	0.653
S02.0 Fracture of vault of skull	0.000	0.352	0.648
T48.6 Antiasthmatics, not elsewhere classified	0.646	0.354	0.000
S06.7 Intracranial injury with prolonged coma	0.000	0.358	0.642
S06.1 Traumatic cerebral oedema	0.000	0.358	0.642
S06.4 Epidural haemorrhage	0.000	0.364	0.636
S02.90 Fracture of skull and facial bones, part unspecified (closed)	0.000	0.371	0.629
S00.4 Superficial injury of ear	0.000	0.376	0.624
L40-L45 Papulosquamous disorders	0.623	0.377	0.000
S02.61 Fracture of mandible (open)	0.000	0.377	0.623
J33.8 Other polyp of sinus	0.000	0.383	0.617
J46 Status asthmaticus	0.000	0.387	0.613
J84.8 Other specified interstitial pulmonary diseases	0.000	0.389	0.610
S02.1 Fracture of base of skull	0.000	0.394	0.606
J85-J86 Suppurative and necrotic conditions of lower respiratory tract	0.000	0.395	0.605
S06.5 Traumatic subdural haemorrhage	0.000	0.395	0.604
S06.8 Other intracranial injuries	0.000	0.400	0.600
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.600	0.400	0.000
S06.60 Traumatic subarachnoid haemorrhage (without open intracranial wound)	0.000	0.403	0.597
J30.3 Other allergic rhinitis	0.000	0.406	0.594
J30.0 Vasomotor rhinitis	0.000	0.411	0.589
K90.3 Pancreatic steatorrhoea	0.000	0.413	0.587
K90.2 Blind loop syndrome, not elsewhere classified	0.000	0.413	0.587
K90.1 Tropical sprue	0.000	0.413	0.587
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.587	0.413	0.000
S02.70 Multiple fractures involving skull and facial bones (closed)	0.000	0.419	0.581
K90.4 Malabsorption due to intolerance, not elsewhere classified	0.000	0.422	0.578
J33.1 Polypoid sinus degeneration	0.000	0.424	0.575
S06.21 Diffuse brain injury (with open intracranial wound)	0.000	0.429	0.571
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.571	0.429	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.568	0.432	0.000
T48.5 Anti-common-cold drugs	0.568	0.432	0.000
T48.4 Expectorants	0.568	0.432	0.000
T48.3 Antitussives	0.568	0.432	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.568	0.432	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.568	0.432	0.000
T48.0 Oxytocic drugs	0.568	0.432	0.000
T46.1 Calcium-channel blockers	0.567	0.433	0.000
T47.0 Histamine H(2)-receptor antagonists	0.555	0.445	0.000
S02.91 Fracture of skull and facial bones, part unspecified (open)	0.000	0.447	0.552
S06.90 Intracranial injury, unspecified (without open intracranial wound)	0.000	0.450	0.549
S06.31 Focal brain injury (with open intracranial wound)	0.000	0.452	0.548
L42 Pityriasis rosea	0.545	0.455	0.000
S02.20 Fracture of nasal bones (closed)	0.000	0.460	0.540
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.540	0.460	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.540	0.460	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.540	0.460	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.540	0.460	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.540	0.460	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.540	0.460	0.000
T44.0 Anticholinesterase agents	0.540	0.460	0.000
S02.71 Multiple fractures involving skull and facial bones (open)	0.000	0.467	0.532
J41 Simple and mucopurulent chronic bronchitis	0.000	0.469	0.531
S02.3 Fracture of orbital floor	0.000	0.474	0.526
J84.0 Alveolar and parietoalveolar conditions	0.000	0.474	0.526
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.522	0.478	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.522	0.478	0.000
T47.7 Emetics	0.522	0.478	0.000
T47.6 Antidiarrhoeal drugs	0.522	0.478	0.000
T47.5 Digestants	0.522	0.478	0.000
T47.4 Other laxatives	0.522	0.478	0.000
T47.3 Saline and osmotic laxatives	0.522	0.478	0.000
T47.2 Stimulant laxatives	0.522	0.478	0.000
S05 Injury of eye and orbit	0.000	0.479	0.521
S06.61 Traumatic subarachnoid haemorrhage (with open intracranial wound)	0.000	0.483	0.517
T41.5 Therapeutic gases	0.512	0.487	0.000
T41.4 Anaesthetic, unspecified	0.512	0.487	0.000
T41.3 Local anaesthetics	0.512	0.487	0.000
T41.2 Other and unspecified general anaesthetics	0.512	0.487	0.000
T41.1 Intravenous anaesthetics	0.512	0.487	0.000
T41.0 Inhaled anaesthetics	0.512	0.487	0.000
T49.9 Topical agent, unspecified	0.512	0.487	0.000
T49.8 Other topical agents	0.512	0.487	0.000
T49.7 Dental drugs, topically applied	0.512	0.487	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.512	0.487	0.000
T49.5 Ophthalmological drugs and preparations	0.512	0.487	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.512	0.487	0.000
T49.3 Emollients, demulcents and protectants	0.512	0.487	0.000
T49.2 Local astringents and local detergents	0.512	0.487	0.000
T49.1 Antipruritics	0.512	0.487	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.512	0.487	0.000
J82 Pulmonary eosinophilia, not elsewhere classified	0.000	0.488	0.512
S06.0 Concussion	0.000	0.489	0.511
J80 Adult respiratory distress syndrome	0.000	0.496	0.504
S04.9 Injury of unspecified cranial nerve	0.000	0.498	0.502
S04.8 Injury of other cranial nerves	0.000	0.498	0.502
S04.7 Injury of accessory nerve	0.000	0.498	0.502
S04.6 Injury of acoustic nerve	0.000	0.498	0.502
S04.5 Injury of facial nerve	0.000	0.498	0.502
S04.4 Injury of abducent nerve	0.000	0.498	0.502
S04.3 Injury of trigeminal nerve	0.000	0.498	0.502
S04.2 Injury of trochlear nerve	0.000	0.498	0.502
S04.1 Injury of oculomotor nerve	0.000	0.498	0.502
S04.0 Injury of optic nerve and pathways	0.000	0.498	0.502
S07.9 Crushing injury of head, part unspecified	0.000	0.498	0.502
S07.8 Crushing injury of other parts of head	0.000	0.498	0.502
S07.1 Crushing injury of skull	0.000	0.498	0.502
S07.0 Crushing injury of face	0.000	0.498	0.502
S08.9 Traumatic amputation of unspecified part of head	0.000	0.498	0.502
S08.8 Traumatic amputation of other parts of head	0.000	0.498	0.502
S08.1 Traumatic amputation of ear	0.000	0.498	0.502
S08.0 Avulsion of scalp	0.000	0.498	0.502
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.501	0.498	0.000
T37.5 Antiviral drugs	0.501	0.498	0.000
T37.4 Anthelminthics	0.501	0.498	0.000
T37.3 Other antiprotozoal drugs	0.501	0.498	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.501	0.498	0.000
T37.1 Antimycobacterial drugs	0.501	0.498	0.000
T37.0 Sulphonamides	0.501	0.498	0.000
S01.9 Open wound of head, part unspecified	0.000	0.499	0.501
T47.1 Other antacids and anti-gastric-secretion drugs	0.498	0.502	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.498	0.502	0.000
S06.91 Intracranial injury, unspecified (with open intracranial wound)	0.000	0.502	0.497
J36 Peritonsillar abscess	0.000	0.503	0.497
S03.5 Sprain and strain of joints and ligaments of other and unspecified parts of head	0.000	0.505	0.495
S03.4 Sprain and strain of jaw	0.000	0.505	0.495
S03.3 Dislocation of other and unspecified parts of head	0.000	0.505	0.495
S03.1 Dislocation of septal cartilage of nose	0.000	0.505	0.495
S03.0 Dislocation of jaw	0.000	0.505	0.495
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.494	0.506	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.494	0.506	0.000
T46.7 Peripheral vasodilators	0.494	0.506	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.494	0.506	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.494	0.506	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.493	0.507	0.000
J37 Chronic laryngitis and laryngotracheitis	0.000	0.509	0.491
S02.21 Fracture of nasal bones (open)	0.000	0.512	0.488
J96 Respiratory failure, not elsewhere classified	0.000	0.513	0.487
T37.8 Other specified systemic anti-infectives and antiparasitics	0.486	0.514	0.000
S03.2 Dislocation of tooth	0.000	0.515	0.485
S02.51 Fracture of tooth (open)	0.000	0.520	0.480
T36.9 Systemic antibiotic, unspecified	0.479	0.520	0.000
T36.8 Other systemic antibiotics	0.479	0.520	0.000
T36.7 Antifungal antibiotics, systemically used	0.479	0.520	0.000
T36.6 Rifamycins	0.479	0.520	0.000
T36.5 Aminoglycosides	0.479	0.520	0.000
T36.4 Tetracyclines	0.479	0.520	0.000
T36.3 Macrolides	0.479	0.520	0.000
T36.2 Chloramphenicol group	0.479	0.520	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.479	0.520	0.000
M07 Psoriatic and enteropathic arthropathies	0.479	0.521	0.000
J86 Pyothorax	0.000	0.522	0.477
J85 Abscess of lung and mediastinum	0.000	0.526	0.474
T46.3 Coronary vasodilators, not elsewhere classified	0.469	0.531	0.000
S02.01 Fracture of vault of skull (open)	0.000	0.535	0.464
S06.11 Traumatic cerebral oedema (with open intracranial wound)	0.000	0.540	0.460
S06.10 Traumatic cerebral oedema (without open intracranial wound)	0.000	0.540	0.460
S06.71 Intracranial injury with prolonged coma (with open intracranial wound)	0.000	0.540	0.460
S06.70 Intracranial injury with prolonged coma (without open intracranial wound)	0.000	0.540	0.460
T46.5 Other antihypertensive drugs, not elsewhere classified	0.460	0.540	0.000
J30.2 Other seasonal allergic rhinitis	0.000	0.542	0.458
S06.41 Epidural haemorrhage (with open intracranial wound)	0.000	0.544	0.456
S02.50 Fracture of tooth (closed)	0.000	0.544	0.456
J81 Pulmonary oedema	0.000	0.547	0.453
L43 Lichen planus	0.452	0.548	0.000
S06.40 Epidural haemorrhage (without open intracranial wound)	0.000	0.550	0.450
L44 Other papulosquamous disorders	0.447	0.553	0.000
L41 Parapsoriasis	0.447	0.553	0.000
L45 Papulosquamous disorders in diseases classified elsewhere	0.447	0.553	0.000
J99.1 Respiratory disorders in other diffuse connective tissue disorders	0.000	0.558	0.442
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.439	0.561	0.000
T40.1 Heroin	0.436	0.564	0.000
T36.0 Penicillins	0.433	0.566	0.000
S06.51 Traumatic subdural haemorrhage (with open intracranial wound)	0.000	0.566	0.433
S06.81 Other intracranial injuries (with open intracranial wound)	0.000	0.569	0.430
J99.0 Rheumatoid lung disease	0.000	0.572	0.428
J86.0 Pyothorax with fistula	0.000	0.575	0.424
T46.4 Angiotensin-converting-enzyme inhibitors	0.421	0.578	0.000
S02.11 Fracture of base of skull (open)	0.000	0.581	0.419
S02.00 Fracture of vault of skull (closed)	0.000	0.582	0.418
J90-J94 Other diseases of pleura	0.000	0.583	0.417
J00-J06 Acute upper respiratory infections	0.000	0.586	0.414
J43 Emphysema	0.000	0.588	0.412
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.409	0.591	0.000
T40.8 Lysergide [LSD]	0.409	0.591	0.000
T40.7 Cannabis (derivatives)	0.409	0.591	0.000
T40.5 Cocaine	0.409	0.591	0.000
T40.3 Methadone	0.409	0.591	0.000
T40.0 Opium	0.409	0.591	0.000
J39 Other diseases of upper respiratory tract	0.000	0.593	0.407
S05.9 Injury of eye and orbit, part unspecified	0.000	0.600	0.400
J47 Bronchiectasis	0.000	0.601	0.399
S06.50 Traumatic subdural haemorrhage (without open intracranial wound)	0.000	0.604	0.396
J03 Acute tonsillitis	0.000	0.610	0.390
S06.80 Other intracranial injuries (without open intracranial wound)	0.000	0.611	0.389
S05.8 Other injuries of eye and orbit	0.000	0.616	0.384
J44 Other chronic obstructive pulmonary disease	0.000	0.618	0.382
J41.8 Mixed simple and mucopurulent chronic bronchitis	0.000	0.619	0.381
J41.1 Mucopurulent chronic bronchitis	0.000	0.619	0.381
S05.0 Injury of conjunctiva and corneal abrasion without mention of foreign body	0.000	0.619	0.381
T40.6 Other and unspecified narcotics	0.377	0.622	0.000
S02.31 Fracture of orbital floor (open)	0.000	0.623	0.377
J41.0 Simple chronic bronchitis	0.000	0.624	0.376
T45.0 Antiallergic and antiemetic drugs	0.375	0.624	0.000
S05.7 Avulsion of eye	0.000	0.626	0.374
S05.6 Penetrating wound of eyeball without foreign body	0.000	0.626	0.374
S05.4 Penetrating wound of orbit with or without foreign body	0.000	0.626	0.374
J03.9 Acute tonsillitis, unspecified	0.000	0.627	0.373
J85.1 Abscess of lung with pneumonia	0.000	0.627	0.373
S05.5 Penetrating wound of eyeball with foreign body	0.000	0.628	0.371
J98 Other respiratory disorders	0.000	0.631	0.369
S02.10 Fracture of base of skull (closed)	0.000	0.633	0.367
J85.2 Abscess of lung without pneumonia	0.000	0.633	0.367
S01.0 Open wound of scalp	0.000	0.633	0.367
S06.01 Concussion (with open intracranial wound)	0.000	0.633	0.366
L43.8 Other lichen planus	0.366	0.634	0.000
J91 Pleural effusion in conditions classified elsewhere	0.000	0.639	0.361
T40.2 Other opioids	0.361	0.639	0.000
J93 Pneumothorax	0.000	0.641	0.359
T45.9 Primarily systemic and haematological agent, unspecified	0.357	0.643	0.000
T45.8 Other primarily systemic and haematological agents	0.357	0.643	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.357	0.643	0.000
T45.6 Fibrinolysis-affecting drugs	0.357	0.643	0.000
T45.4 Iron and its compounds	0.357	0.643	0.000
T45.3 Enzymes, not elsewhere classified	0.357	0.643	0.000
J30.4 Allergic rhinitis, unspecified	0.000	0.647	0.353
J37.1 Chronic laryngotracheitis	0.000	0.648	0.352
T45.2 Vitamins, not elsewhere classified	0.349	0.650	0.000
J20-J22 Other acute lower respiratory infections	0.000	0.651	0.349
J96.9 Respiratory failure, unspecified	0.000	0.651	0.349
J96.1 Chronic respiratory failure	0.000	0.651	0.349
J96.0 Acute respiratory failure	0.000	0.651	0.349
S05.3 Ocular laceration without prolapse or loss of intraocular tissue	0.000	0.653	0.347
T43.0 Tricyclic and tetracyclic antidepressants	0.344	0.655	0.000
M07.6 Other enteropathic arthropathies	0.344	0.656	0.000
M07.5 Arthropathy in ulcerative colitis	0.344	0.656	0.000
M07.4 Arthropathy in Crohn's disease [regional enteritis]	0.344	0.656	0.000
M07.2 Psoriatic spondylitis	0.344	0.656	0.000
M07.1 Arthritis mutilans	0.344	0.656	0.000
M07.0 Distal interphalangeal psoriatic arthropathy	0.344	0.656	0.000
J44.8 Other specified chronic obstructive pulmonary disease	0.000	0.658	0.342
J85.3 Abscess of mediastinum	0.000	0.660	0.340
T40.4 Other synthetic narcotics	0.336	0.664	0.000
S09 Other and unspecified injuries of head	0.000	0.665	0.335
J39.2 Other diseases of pharynx	0.000	0.671	0.329
J42 Unspecified chronic bronchitis	0.000	0.673	0.327
L43.3 Subacute (active) lichen planus	0.324	0.676	0.000
L43.2 Lichenoid drug reaction	0.324	0.676	0.000
L43.1 Bullous lichen planus	0.324	0.676	0.000
L43.0 Hypertrophic lichen planus	0.324	0.676	0.000
S00.8 Superficial injury of other parts of head	0.000	0.678	0.322
L41.9 Parapsoriasis, unspecified	0.321	0.679	0.000
L41.8 Other parapsoriasis	0.321	0.679	0.000
L41.5 Retiform parapsoriasis	0.321	0.679	0.000
L41.4 Large plaque parapsoriasis	0.321	0.679	0.000
L41.3 Small plaque parapsoriasis	0.321	0.679	0.000
L41.2 Lymphomatoid papulosis	0.321	0.679	0.000
L41.1 Pityriasis lichenoides chronica	0.321	0.679	0.000
L41.0 Pityriasis lichenoides et varioliformis acuta	0.321	0.679	0.000
L44.9 Papulosquamous disorder, unspecified	0.321	0.679	0.000
L44.8 Other specified papulosquamous disorders	0.321	0.679	0.000
L44.4 Infantile papular acrodermatitis [Giannotti-Crosti]	0.321	0.679	0.000
L44.3 Lichen ruber moniliformis	0.321	0.679	0.000
L44.2 Lichen striatus	0.321	0.679	0.000
L44.1 Lichen nitidus	0.321	0.679	0.000
L44.0 Pityriasis rubra pilaris	0.321	0.679	0.000
J85.0 Gangrene and necrosis of lung	0.000	0.681	0.319
J98.6 Disorders of diaphragm	0.000	0.683	0.317
J37.0 Chronic laryngitis	0.000	0.683	0.317
J60-J70 Lung diseases due to external agents	0.000	0.686	0.314
J43.2 Centrilobular emphysema	0.000	0.687	0.313
J98.0 Diseases of bronchus, not elsewhere classified	0.000	0.688	0.312
J35 Chronic diseases of tonsils and adenoids	0.000	0.694	0.306
J93.9 Pneumothorax, unspecified	0.000	0.695	0.305
S05.2 Ocular laceration and rupture with prolapse or loss of intraocular tissue	0.000	0.698	0.302
J43.1 Panlobular emphysema	0.000	0.704	0.296
J43.0 MacLeod's syndrome	0.000	0.704	0.296
J31 Chronic rhinitis, nasopharyngitis and pharyngitis	0.001	0.706	0.293
J39.3 Upper respiratory tract hypersensitivity reaction, site unspecified	0.000	0.708	0.292
J39.1 Other abscess of pharynx	0.000	0.708	0.292
J43.8 Other emphysema	0.000	0.708	0.291
J05 Acute obstructive laryngitis [croup] and epiglottitis	0.000	0.711	0.289
J98.8 Other specified respiratory disorders	0.000	0.712	0.288
J94 Other pleural conditions	0.000	0.717	0.283
J02 Acute pharyngitis	0.000	0.718	0.282
J93.1 Other spontaneous pneumothorax	0.000	0.718	0.282
J03.8 Acute tonsillitis due to other specified organisms	0.000	0.720	0.280
J03.0 Streptococcal tonsillitis	0.000	0.720	0.280
F30-F39 Mood [affective] disorders	0.277	0.723	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.275	0.724	0.001
F30 Manic episode	0.275	0.725	0.000
J04 Acute laryngitis and tracheitis	0.000	0.726	0.274
J39.0 Retropharyngeal and parapharyngeal abscess	0.000	0.731	0.269
S05.1 Contusion of eyeball and orbital tissues	0.000	0.731	0.269
L43.9 Lichen planus, unspecified	0.268	0.732	0.000
F31 Bipolar affective disorder	0.267	0.733	0.000
S00.9 Superficial injury of head, part unspecified	0.000	0.734	0.266
J98.3 Compensatory emphysema	0.000	0.735	0.265
J93.0 Spontaneous tension pneumothorax	0.000	0.736	0.264
J20 Acute bronchitis	0.000	0.737	0.263
J98.2 Interstitial emphysema	0.000	0.738	0.262
F33 Recurrent depressive disorder	0.262	0.738	0.000
F30.9 Manic episode, unspecified	0.257	0.743	0.000
J93.8 Other pneumothorax	0.000	0.748	0.252
J21 Acute bronchiolitis	0.000	0.749	0.251
J44.1 Chronic obstructive pulmonary disease with acute exacerbation, unspecified	0.000	0.749	0.251
J96.09 Acute respiratory failure; Type unspecified	0.000	0.749	0.250
J96.01 Acute respiratory failure; Type II [hypercapnic]	0.000	0.749	0.250
J96.00 Acute respiratory failure; Type I [hypoxic]	0.000	0.749	0.250
J96.19 Chronic respiratory failure; Type unspecified	0.000	0.749	0.250
J96.11 Chronic respiratory failure; Type II [hypercapnic]	0.000	0.749	0.250
J96.10 Chronic respiratory failure; Type I [hypoxic]	0.000	0.749	0.250
J96.99 Respiratory failure, unspecified; Type unspecified	0.000	0.749	0.250
J96.91 Respiratory failure unspecified; Type II [hypercapnic]	0.000	0.749	0.250
J96.90 Respiratory failure, unspecified; Type I [hypoxic]	0.000	0.749	0.250
T45.5 Anticoagulants	0.250	0.750	0.001
J67 Hypersensitivity pneumonitis due to organic dust	0.000	0.751	0.249
J39.9 Disease of upper respiratory tract, unspecified	0.000	0.752	0.247
M07.09 Distal interphalangeal psoriatic arthropathy (Site unspecified)	0.246	0.753	0.000
M07.08 Distal interphalangeal proriatic arthropathy-Other	0.246	0.753	0.000
M07.07 Distal interphalangeal psoriatic arthropathy (Ankle and foot)	0.246	0.753	0.000
M07.06 Distal interphalangeal proriatic arthropathy-Lower leg	0.246	0.753	0.000
M07.05 Distal interphalangeal proriatic arthropathy-Pelvic/thigh	0.246	0.753	0.000
M07.04 Distal interphalangeal psoriatic arthropathy (Hand)	0.246	0.753	0.000
M07.03 Distal interphalangeal proriatic arthropathy-Forearm	0.246	0.753	0.000
M07.02 Distal interphalangeal proriatic arthropathy-Upper arm	0.246	0.753	0.000
M07.01 Distal interphalangeal proriatic arthropathy-Shldr region	0.246	0.753	0.000
M07.00 Distal interphalangeal psoriatic arthropathy (Multiple sites)	0.246	0.753	0.000
M07.19 Arthritis mutilans (Site unspecified)	0.246	0.753	0.000
M07.18 Arthritis mutilans (Other)	0.246	0.753	0.000
M07.17 Arthritis mutilans (Ankle and foot)	0.246	0.753	0.000
M07.16 Arthritis mutilans (Lower leg)	0.246	0.753	0.000
M07.15 Arthritis mutilans (Pelvic region and thigh)	0.246	0.753	0.000
M07.14 Arthritis mutilans (Hand)	0.246	0.753	0.000
M07.13 Arthritis mutilans (Forearm)	0.246	0.753	0.000
M07.12 Arthritis mutilans (Upper arm)	0.246	0.753	0.000
M07.11 Arthritis mutilans (Shoulder region)	0.246	0.753	0.000
M07.10 Arthritis mutilans (Multiple sites)	0.246	0.753	0.000
M07.29 Psoriatic spondylitis (Site unspecified)	0.246	0.753	0.000
M07.28 Psoriatic spondylitis (Other)	0.246	0.753	0.000
M07.27 Psoriatic spondylitis (Ankle and foot)	0.246	0.753	0.000
M07.26 Psoriatic spondylitis (Lower leg)	0.246	0.753	0.000
M07.25 Psoriatic spondylitis (Pelvic region and thigh)	0.246	0.753	0.000
M07.24 Psoriatic spondylitis (Hand)	0.246	0.753	0.000
M07.23 Psoriatic spondylitis (Forearm)	0.246	0.753	0.000
M07.22 Psoriatic spondylitis (Upper arm)	0.246	0.753	0.000
M07.21 Psoriatic spondylitis (Shoulder region)	0.246	0.753	0.000
M07.20 Psoriatic spondylitis (Multiple sites)	0.246	0.753	0.000
M07.49 Arthropathy in Crohn's disease [regional enteritis] (Site unspecified)	0.246	0.753	0.000
M07.48 Arthropathy in Crohn's disease [regional enteritis] (Other)	0.246	0.753	0.000
M07.47 Arthropathy in Crohn's disease [regional enteritis] (Ankle and foot)	0.246	0.753	0.000
M07.46 Arthropathy in Crohn's disease [regional enteritis] (Lower leg)	0.246	0.753	0.000
M07.45 Arthropathy in Crohn's disease [regional enteritis] (Pelvic region and thigh)	0.246	0.753	0.000
M07.44 Arthropathy in Crohn's disease [regional enteritis] (Hand)	0.246	0.753	0.000
M07.43 Arthropathy in Crohn's disease [regional enteritis] (Forearm)	0.246	0.753	0.000
M07.42 Arthropathy in Crohn's disease [regional enteritis] (Upper arm)	0.246	0.753	0.000
M07.41 Arthropathy in Crohn's disease [regional enteritis] (Shoulder region)	0.246	0.753	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations